Effects of coffee on type 2 diabetes mellitus

Nutrition

Volumn 30, Issue 7-8, 2014, Pages 755-763

  Akash, Muhammad Sajid Hamid ^a,b   Rehman, Kanwal ^a   Chen, Shuqing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

Author keywords

Chlorogenic acid; Coffee consumption; Diabetes mellitus; Glucose homeostasis; Inflammatory biomarkers; Insulin sensitivity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE 6 PHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6; MAGNESIUM; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; COFFEE; GLUCOSE BLOOD LEVEL;

ANTIOXIDANT ACTIVITY; COFFEE; DIETARY INTAKE; DISEASE COURSE; ENZYME INHIBITION; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HUMAN; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAGNESIUM BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; RISK FACTOR; RISK REDUCTION; WEIGHT REDUCTION; CHEMISTRY; COFFEA; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; METABOLISM; PHYTOTHERAPY;

BLOOD GLUCOSE; COFFEA; COFFEE; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; OXIDATIVE STRESS; PHYTOTHERAPY;

EID: 84898412790     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.11.020     Document Type: Review

References (184)

1. Ejaz N., Nisa A., Akmal J., Muhammad A. Comparative study of physico-chemical parameters of different samples of non-branded tea. Pak J Biochem Mol Biol 2004, 37:17-20.
2. Kleemola P., Jousilahti P., Pietinen P., Vartiainen E., Tuomilehto J. Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med 2000, 160:3393-3400.
3. Robertson D., Hollister A.S., Kincaid D., Workman R., Goldberg M.R., Tung C.S., et al. Caffeine and hypertension. Am J Med 1984, 77:54-60.
4. Zeegers M.P., Tan F.E., Goldbohm R.A., van den Brandt P.A. Are coffee and tea consumption associated with urinary tract cancer risk? a systematic review and meta-analysis. Int J Epidemiol 2001, 30:353-362.
5. Leitzmann M.F., Willett W.C., Rimm E.B., Stampfer M.J., Spiegelman D., Coldtiz G.A., et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA 1999, 281:2106-2112.
6. Ross G.W., Abbott R.D., Petrovitch H., Morens D.M., Grandinetti A., Tung K.H., et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000, 283:2674-2679.
7. Ferrini R.L., Barrett-Connor E. Caffeine intake and endogenous sex steroid levels in postmenopausal women: the Rancho Bernardo Study. Am J Epidemiol 1996, 144:642-644.
8. Nagata C., Kabuto M., Shimizu H. Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr Cancer 1998, 30:21-24.
9. Goodman-Gruen D., Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 2001, 131:1202-1206.
10. Curhan G.C., Willett W.C., Speizer F.E., Stampfer M.J. Beverage use and risk for kidney stones in women. Ann Intern Med 1998, 128:534-540.
11. Pizziol A., Tikhonoff V., Paleari C.D., Russo E., Mazza A., Ginocchio G., et al. Effects of caffeine on glucose tolerance: a placebo-controlled study. Eur J Clin Nutr 1998, 52:846-849.
12. Keijzers G.B., De Galan B.E., Tack C.J., Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care 2002, 25:364-369.
13. van Dam R.M., Feskens E.J. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002, 360:1477-1478.
14. Akash M.S.H., Shen Q., Rehman K., Chen S. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci 2012, 101:1647-1658.
15. Anjum R., Zahra N., Rehman K., Alam R., Parveen A., Akash M.S.H. Comparative analysis of serum lipid profile between normotensive and hypertensive Pakistani pregnant women. J Mol Genet Med 2013, 7:64.
16. Akash M.S.H., Rehman K., Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem 2013, 114:525-531.
17. Akash M.S.H., Rehman K., Chen S. An overview of valuable scientific models for diabetes mellitus. Curr Diabetes Rev 2013, 9:286-293.
18. El-Kaissi S., Sherbeeni S. Pharmacological management of type 2 diabetes mellitus: an update. Curr Diabetes Rev 2011, 7:392-405.
19. Akash M.S.H., Rehman K., Sun H., Chen S. Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats. Eur J Pharmacol 2013, 701:87-95.
20. Akash M.S.H., Rehman K., Sun H., Chen S. Sustained delivery of IL-1 Ra from PF127 gel reduces hyperglycemia in diabetic GK rats. PLoS One 2013, 8:e55925.
21. Akash M.S.H., Rehman K., Gillani Z., Sun H., Chen S. Cross-species comparison of IL-1 Ra sequence between human and rat. J Proteomics Bioinform 2013, 6:38-42.
22. Akash M.S.H., Rehman K., Li N., Gao J.Q., Sun H., Chen S. Sustained delivery of IL-1 Ra from Pluronic F127-based thermosensitive gel prolongs its therapeutic potentials. Pharm Res 2012, 29:3475-3485.
23. Akash M.S.H., Rehman K., Chen S. IL-1 Ra and its delivery strategies: inserting the association in perspective. Pharm Res 2013, 30:2951-2966.
24. Akash M.S.H., Rehman K., Sun H., Chen S. Assessment of release kinetics, stability and polymer interaction of PF127-based thermosensitive gel of IL-1 Ra. Pharm Dev Technol 2014, 19:278-284. 10.3109/10837450.2013775158.
25. Mathur M.L., Gaur J., Sharma R., Haldiya K.R. Antidiabetic properties of a spice plant Nigella sativa. J Endocrinol Metab 2011, 1:1-8.
26. Akash M.S.H., Rehman K., Rasool F., Sethi A., Abrar M.A., Irshad A., et al. Alternate therapy of type 2 diabetes mellitus (T2 DM) with Nigella (Ranunculaceae). J Med Plants Res 2011, 5:6885-6889.
27. Elosta A., Ghous T., Ahmed N. Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications. Curr Diabetes Rev 2012, 8:92-108.
28. Rehman K., Akash M.S.H., Azhar S., Khan S.A., Abid R., Waseem A., et al. A biochemical and histopathologic study showing protection and treatment of gentamicin-induced nephrotoxicity in rabbits using vitamin C. Afr J Tradit Complement Altern Med 2012, 9:360-365.
29. Ibrahim M., Farooq T., Hussain N., Hussain A., Gulzar T., Hussain I., et al. Acetyl and butyryl cholinesterase inhibitory sesquiterpene lactones from Amberboa ramose. Chem Cent J 2013, 7:116.
30. Clifford M.N. Chlorogenic acid and other cinnamates-nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric 2000, 80:1033-1043.
31. Higdon J.V., Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006, 46:101-123.
32. James J.E. Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously. Psychosom Med 2004, 66:63-71.
33. Temple J.L. Caffeine use in children: what we know, what we have left to learn, and why we should worry. Neurosci Biobehav Rev 2009, 33:793-806.
34. Campbell B., Wilborn C., La Bounty P., Taylor L., Nelson M.T., Greenwood M., et al. International Society of Sports Nutrition position stand: energy drinks. J Int Soc Sports Nutr 2013, 10:1.
35. Bridge C.A., Jones M.A. The effect of caffeine ingestion on 8 km run performance in a field setting. J Sports Sci 2006, 24:433-439.
36. Mc Naughton L.R., Lovell R.J., Siegler J.C., Midgley A.W., Sandstrom M., Bentley D.J. The effects of caffeine ingestion on time trial cycling performance. J Sports Med Phys Fitness 2008, 48:320-325.
37. Smith A. Effects of caffeine on human behavior. Food Chem Toxicol 2002, 40:1243-1255.
38. Tuomilehto J., Hu G., Bidel S., Lindström J., Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 2004, 291:1213-1219.
39. Naismith D.J., Akinyanju P.A., Szanto S., Yudkin J. The effect, in volunteers, of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting. Nutr Metab 1970, 12:144-151.
40. Isogawa A., Noda M., Takahashi Y., Kadowaki T., Tsugane S. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2003, 361:703-704.
41. Carlsson S., Hammar N., Grill V., Kaprio J. Coffee consumption and risk of type 2 diabetes in Finnish twins. Int J Epidemiol 2004, 33:616-617.
42. Rosengren A., Dotevall A., Wilhelmsen L., Thelle D., Johansson S. Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med 2004, 255:89-95.
43. Salazar-Martinez E., Willett W.C., Ascherio A., Manson J.E., Leitzmann M.F., Stampfer M.J., et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004, 140:1-8.
44. Sartorelli D.S., Fagherazzi G., Balkau B., Touillaud M.S., Boutron-Ruault M.C., de Lauzon-Guillain B., et al. Differential effects of coffee on the risk of type 2 diabetes according to meal consumption in a French cohort of women: the E3 N/EPIC cohort study. Am J Clin Nutr 2010, 91:1002-1012.
45. Reunanen A., Heliovaara M., Aho K. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2003, 361:702-703.
46. van Dam R.M., Dekker J.M., Nijpels G., Stehouwer C.D., Bouter L.M., Heine R.J. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia 2004, 47:2152-2159. Hoorn study.
47. Agardh E.E., Carlsson S., Ahlbom A., Efendic S., Grill V., Hammar N., et al. Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 2004, 255:645-652.
48. Hamer M., Witte D.R., Mosdol A., Marmot M.G., Brunner E.J. Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: The Whitehall II study. Br J Nutr 2008, 100:1046-1053.
49. Bidel S., Silventoinen K., Hu G., Lee D.H., Kaprio J., Tuomilehto J. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur J Clin Nutr 2008, 62:178-185.
50. Van Dieren S., Uiterwall C.S., van der Schouw Y.T., van der A.D.L., Boer J.M., Spijkerman A., et al. Coffee and tea consumption and risk of type 2 diabetes. Diabetologia 2009, 52:2561-2569.
51. Zhang Y., Lee E.T., Cowan L.D., Fabsitz R.R., Howard B.V. Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: the Strong Heart Study. Nutr Metab Cardiovasc Dis 2010, 21:418-423.
52. Paynter N.P., Yeh H.C., Voutilainen S., Schmidt M.I., Heiss G., Folsom A.R., et al. Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Am J Epidemiol 2006, 164:1075-1084.
53. Pereira M.A., Parker E.D., Folsom A.R. Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28,812 postmenopausal women. Arch Intern Med 2006, 166:1311-1316.
54. Zhang W., Lopez-Garcia E., Li T.Y., Hu F.B., van Dam R.M. Coffee consumption and risk of cardiovascular diseases and all-cause mortality among men with type 2 diabetes. Diabetes Care 2009, 32:1043-1045.
55. Boggs D.A., Rosenberg L., Ruiz-Narvaez E.A., Palmer J.R. Coffee, tea, and alcohol intake in relation to risk of type 2 diabetes in African American women. Am J Clin Nutr 2010, 92:960-966.
56. Fuhrman B.J., Smit E., Crespo C.J., Garcia-Palmieri M.R. Coffee intake and risk of incident diabetes in Puerto Rican men: results from the Puerto Rico Heart Health Program. Public Health Nutr 2009, 12:842-848.
57. Saremi A., Tulloch-Reid M., Knowler W.C. Coffee consumption and the incidence of type 2 diabetes. Diabetes Care 2003, 26:2211-2212.
58. Odegaard A.O., Pereira M.A., Koh W.P., Arakawa K., Lee H.P., Yu M.C. Coffee, tea, and incident type 2 diabetes: the Singapore Chinese health study. Am J Clin Nutr 2008, 88:979-985.
59. Kato M., Noda M., Inoue M., Kadowaki T., Tsugane S. Psychological factors, coffee and risk of diabetes mellitus among middle-aged Japanese: a population-based prospective study in the JPHC study cohort. Endocr J 2009, 56:459-468. JPHC Study Group.
60. Oba S., Nagata C., Nakamura K., Fujii K., Kawachi T., Takatsuka N., et al. Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr 2010, 103:453-459.
61. Lin W.Y., Xiaver Pi-Sunyer F., Chen C.C., Davidson L.E., Liu C.S., Li T.C., et al. Coffee consumption is inversely associated with type 2 diabetes in Chinese. Eur J Clin Invest 2011, 41:659-666.
62. van Dam R.M., Hu F.B. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005, 294:97-104.
63. Huxley R., Lee C.M., Barzi F., Timmermeister L., Czernichow S., Perkovic V., et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 2009, 169:2053-2063.
64. Bilal A., Rehman K., Akash M.S.H., Hussain K., Ibrahim M., Hussan S.S. Development and validation of analytical method for qualitative and quantitative determination of glibenclamide in different brands of tablet dosage Ffrm using UV-visible spectroscopy. J Mol Genet Med 2013, 7:80.
65. Petrie H.J., Chown S.E., Belfie L.M., Duncan A.M., McLaren D.H., Conquer J.A., et al. Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. Am J Clin Nutr 2004, 80:22-28.
66. Lane J.D., Barkauskas C.E., Surwit R.S., Feinglos M.N. Caffeine impairs glucose metabolism in type 2 diabetes. Diabetes Care 2004, 27:2047-2048.
67. Yamaji T., Mizoue T., Tabata S., Ogawa S., Yamaguchi K., Shimizu E., et al. Coffee consumption and glucose tolerance status in middle-aged Japanese men. Diabetologia 2004, 47:2145-2151.
68. Arnlov J., Vessby B., Riserus U. Coffee consumption and insulin sensitivity. JAMA 2004, 291:1199-1201.
69. Wu T., Willett W.C., Hankinson S.E., Giovannucci E. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 2005, 28:1390-1396.
70. Bidel S., Hu G., Sundvall J., Kaprio J., Tuomilehto J. Effects of coffee consumption on glucose tolerance, serum glucose and insulin levels- a cross-sectional analysis. Horm Metab Res 2006, 38:38-43.
71. Smith B., Wingard D.L., Smith T.C., Kritz-Silverstein D., Barrett-Connor E. Does coffee consumption reduce the risk of type 2 diabetes in individuals with impaired glucose?. Diabetes Care 2006, 29:2385-2390.
72. Greer F., Hudson R., Ross R., Graham T. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes 2001, 50:2349-2354.
73. Thong F.S., Graham T.E. Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol 2002, 92:2347-2352.
74. Mackenzie T., Comi R., Sluss P., Keisari R., Manwar S., Kim J., et al. Metabolic and hormonal effects of caffeine: randomized, double-blind placebo-controlled crossover trial. Metabolism 2007, 56:1694-1698.
75. Muley A., Muley P., Shah M. Coffee to reduce risk of type 2 diabetes?: a systematic review. Curr Diabetes Rev 2012, 8:162-168.
76. Denaro C.P., Brown C.R., Jacob P., Benowitz N.L. Effects of caffeine with repeated dosing. Eur J Clin Pharmacol 1991, 40:273-278.
77. Shearer J., Farah A., de Paulis T., Bracy D.P., Pencek R.R., Graham T.E., et al. Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr 2003, 133:3529-3532.
78. Johnston K.L., Clifford M.N., Morgan L.M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003, 78:728-733.
79. Shearer J., Sellars E.A., Farah A., Graham T.E., Wasserman D.H. Effect of chronic coffee consumption on glucose kinetics in the conscious rat. Can J Physiol Pharmacol 2007, 85:823-830.
80. Zampelas A., Panagiotakos D.B., Pitsavos C., Chrysohoou C., Stefanadis C. Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 2004, 80:862-867.
81. Lopez-Garcia E., van Dam R.M., Qi L., Hu F.B. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 2006, 84:888-893.
82. Williams C.J., Fargnoli J.L., Hwang J.J., van Dam R.M., Blackburn G.L., Hu F.B., et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 2008, 31:504-507.
83. Kotani K., Tsuzaki K., Sano Y., Maekawa M., Fujiwara S., Hamada T., et al. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med 2008, 46:1434-1437.
84. Arsenault B.J., Earnest C.P., Despres J.P., Blair S.N., Church T.S. Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use. Eur J Clin Nutr 2009, 63:1419-1424.
85. Fukushima Y., Kasuga M., Nakao K., Shimomura I., Matsuzawa Y. Effects of coffee on inflammatory cytokine gene expression in mice fed high-fat diets. J Agric Food Chem 2009, 57:11100-11105.
86. Yamauchi R., Kobayashi M., Matsuda Y., Ojika M., Shigeoka S., Ymamoto Y., et al. Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice. J Agric Food Chem 2010, 58:5597-5603.
87. Vitaglione P., Morisco F., Mazzone G., Amoruso D.C., Ribecco M.T., Romano A., et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010, 52:1652-1661.
88. Kempf K., Herder C., Erlund I., Kolb H., Martin S., Carstensen M., et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 2010, 91:950-957.
89. Pham N.M., Wang Z., Morita M., Ohnaka K., Adachi M., Kawate H., et al. Combined effects of coffee consumption and serum γ-glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women. Clin Chem Lab Med 2011, 49:1661-1667.
90. Imatoh T., Tanihara S., Miyazaki M., Momose Y., Uryu Y., Une H. Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males. Eur J Nutr 2011, 50:279-284.
91. Sethi G., Sung B., Aggarwal B.B. Nuclear factor-kB activation: from bench to bedside. Exp Biol Med 2008, 233:21-31.
92. Holmes-McNary M., Baldwin A.S. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the Ikappa B kinase. Cancer Res 2000, 60:3477-3483.
93. Kim S.H., Shin K.J., Kim D., Kim Y.H., Han M.S., Lee T.G., et al. Luteolin inhibits the nuclear factor-kappa B transcriptional activity in Rat-1 fibroblasts. Biochem Pharmacol 2003, 66:955-963.
94. Feng R., Lu Y., Bowman L.L., Qian Y., Castranova V., Ding M. Inhibition of AP-1, NF-kappa B and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 2005, 280:27888-27895.
95. Chu Y.F., Chen Y.M., Black R.M., Brown P.H., Lyle B.J., Liu R.H., et al. Type 2 diabetes-related bioactivities of coffee: assessment of antioxidant activity, NF-κB inhibition, and stimulation of glucose uptake. Food Chemistry 2011, 124:914-920.
96. Westergaard N., Madsen P. Glucose-6-phosphatase inhibitors for the treatment of type 2 diabetes. Expert Opin Ther Patents 2001, 11:1429-1441.
97. Monteiro M., Farah A., Perrone D., Trugo L.C., Donangelo C. Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J Nutr 2007, 137:2196-2201.
98. Olthof M.R., Hollman P.C., Katan M.B. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 2001, 131:66-71.
99. Olthof M.R., Hollman P.C., Buijsman M.N., van Amelsvoort J.M., Katan M.B. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr 2003, 133:1806-1814.
100. Clifford M.N. Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J Sci Food Agric 1999, 79:362-372.
101. Arion W.J., Canfield W.K., Ramos F.C., Schindler P.W., Burger H.J., Hemmerle H., et al. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose-6-phosphatase. Arch Biochem Biophys 1997, 339:315-322.
102. Herling A.W., Burger H., Schubert G., Hemmerle H., Schaefer H., Kramer W. Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur J Pharmacol 1999, 386:75-82.
103. Andrade-Cetto A., Wiedenfeld H. Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats. J Ethnopharmacol 2001, 78:145-149.
104. Rodriguez de Sotillo D.V., Hadley M. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem 2002, 13:717-726.
105. Hemmerle H., Burger H.J., Below P., Schubert G., Rippel R., Schindler P.W., et al. Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J Med Chem 1997, 40:137-145.
106. Henry-Vitrac C., Ibarra A., Roller M., Merillon J.M., Vitrac X. Contribution of chlorogenic acids to the inhibition of human hepatic glucose-6-phosphatase activity invitro by Svetol, a standardized decaffeinated green coffee extract. J Agric Food Chem 2010, 58:4141-4144.
107. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 2006, 116:1793-1801.
108. Kempf K., Rathmann W., Herder C. Impaired glucose regulation and type 2 diabetes in children and adolescents. Diabetes Metab Res Rev 2008, 24:427-437.
109. Holten M.K., Zacho M., Gaster M., Juel C., Wojtaszewski J.F., Dela F. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004, 53:294-305.
110. Farah A., de Paulis T., Moreira D.P., Trugo L.C., Martin P.R. Chlorogenic acids and lactones in regular and water-decaffeinated arabica coffees. J Agric Food Chem 2006, 54:374-381.
111. Li Y., Kim J., Li J., Liu F., Liu X., Himmeldirk K., et al. Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway. Biochem Biophys Res Commun 2005, 336:430-437.
112. Muthusamy V.S., Anand S., Sangeetha K.N., Sujatha S., Arun B., Lakshmi B.S. Tannins present in Cichorium intybus enhance glucose uptake and inhibit adipogenesis in 3 T3-L1 adipocytes through PTP1 B inhibition. Chem Biol Interact 2008, 174:69-78.
113. Prabhakar P.K., Doble M. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomedicine 2009, 16:1119-1126.
114. Lee S., Hudson R., Kilpatrick K., Graham T.E., Ross R. Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. Diabetes Care 2005, 28:566-572.
115. Soriguer F., Rojo-Martinez G., de Antonio I.E. Coffee consumption and type 2 diabetes mellitus. Ann Intern Med 2004, 141:321-323.
116. Jensen T.E., Rose A.J., Hellsten Y., Wojtaszewski J.F., Richter E.A. Caffeine-induced Ca(2+) release increases AMPK-dependent glucose uptake in rodent soleus muscle. Am J Physiol Endocrinol Metab 2007, 293:E286-E292.
117. Egawa T., Hamada T., Kameda N., Karaike K., Ma X., Masuda S., et al. Caffeine acutely activates 5'adenosine monophosphate-activated protein kinase and increases insulin-independent glucose transport in rat skeletal muscles. Metabolism 2009, 58:1609-1617.
118. Abbott M.J., Edelman A.M., Turcotte L.P. CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2009, 297:R1724-R1732.
119. McIntosh C.H., Widenmaier S., Kim S.J. Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP). Vitam Horm 2009, 80:409-471.
120. Neff K.J., O'Shea D., le Roux C.W. Glucagon like peptide-1 (GLP-1) dynamics following bariatric surgery: a Signpost to a new frontier. Curr Diabetes Rev 2013, 9:93-101.
121. Meier J.J., Hucking K., Holst J.J., Deacon C.F., Schmiegel W.H., Nauck M.A. Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. Diabetes 2001, 50:2497-2504.
122. Thong F.S.L., Derave W., Kiens B., Graham T.E., Ursø B., Wojtaszewski J.F., et al. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes 2002, 51:583-590.
123. Natella F., Scaccini C. Role of coffee in modulation of diabetes risk. Nutr Rev 2012, 70:207-217.
124. Loopstra-Masters R.C., Liese A.D., Haffner S.M., Wagenknecht L.E., Hanley A.J. Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function. Diabetologia 2011, 54:320-328.
125. Catalano D., Trovato G.M., Spadaro D., Martines G.F., Garufi G., Tonzuso A., et al. Insulin resistance in postmenopausal women: concurrent effects of hormone replacement therapy and coffee. Climacteric 2008, 11:373-382.
126. +/- is expressed in Zucker (fa/fa) rats, and chlorogenic acid modifies their plasma insulin and liver protein and DNA. J Nutr Biochem 2006, 17:63-71.
127. Matsui T., Ueda T., Oki T., Sugita K., Terahara N., Matsumoto K. Alpha-glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity. J Agric Food Chem 2001, 49:1948-1951.
128. Kobayashi Y., Suzuki M., Satsu H., Arai S., Hara Y., Suzuki K., et al. Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J Agric Food Chem 2000, 48:5618-5623.
129. Youn J.H., Youn M.S., Bergman R.N. Synergism of glucose and fructose in net glycogen synthesis in perfused rat livers. J Biol Chem 1996, 261:15960-15969.
130. Jiang R., Manson J.E., Meigs J.B., Ma J., Rifai N., Hu F.B. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004, 291:711-717.
131. Mascitelli L., Pezzetta F., Sullivan J.L. Inhibition of iron absorption by coffee and the reduced risk of type 2 diabetes mellitus. Arch Intern Med 2007, 167:1311-1316.
132. Battram D.S., Arthur R., Weekes A., Graham T.E. The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J Nutr 2006, 136:1276-1280.
133. Robinson L.E., Savani S., Battram D.S., Mclaren D.H., Sathasivam P., Graham T.E. Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. J Nutr 2004, 134:2528-2533.
134. Colditz G.A., Manson J.E., Stampfer M.J., Rosner B., Willett W.C., Speizer F.E. Diet and risk of clinical diabetes in women. Am J Clin Nutr 1992, 55:1018-1023.
135. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
136. Barbagallo M., Dominguez L.J., Galioto A., Ferlisi A., Cani C., Malfa L., et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003, 24:39-52.
137. Paolisso G., Scheen A., D'Onofrio F., Lefebvre P. Magnesium and glucose homeostasis. Diabetologia 1990, 33:511-514.
138. Belin R.J., He K. Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res 2007, 20:107-129.
139. Balon T.W., Jasman A., Scott S., Meehan W.P., Rude R.K., Nadler J.L. Dietary magnesium prevents fructose-induced insulin insensitivity in rats. Hypertension 1994, 23:1036-1039.
140. Balon T.W., Gu J.L., Tokuyama Y., Jasman A.P., Nadler J.L. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol 1995, 269:E745-E752.
141. Saris N.E., Mervaala E., Karppanen H., Khawaja J.A., Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000, 294:1-26.
142. Ma J., Folsom A.R., Melnick S.L., Eckfeldt J.H., Sharrett A.R., Nabulsi A.A., et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study: Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995, 48:927-940.
143. Tosiello L. Hypomagnesemia and diabetes mellitus: a review of clinical implications. Arch Intern Med 1996, 156:1143-1148.
144. Suarez A., Pulido N., Casla A., Casanova B., Arrieta F.J., Rovira A. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 1995, 38:1262-1270.
145. de Valk H.W. Magnesium in diabetes mellitus. Neth J Med 1999, 54:139-146.
146. Rodriguez-Moran M., Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003, 26:1147-1152.
147. Lopez-Ridaura R., Willet W.C., Rimm E.B., Liu S., Stampfer M.J., Manson J.E., et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004, 27:134-140.
148. Kohnert K.D., Freyse E.J., Salzsieder E. Glycaemic variability and pancreatic β-cell dysfunction. Curr Diabetes Rev 2012, 8:345-354.
149. Folli F., Corradi D., Fanti P., Davalli A., Paez A., Giaccari A., et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev 2011, 7:313-324.
150. Shi X., Dalal N.S., Jain A.C. Antioxidant behaviour of caffeine: efficient scavenging of hydroxyl radicals. Food Chem Toxicol 1991, 29:1-6.
151. Kaneto H., Kajimoto Y., Miyagawa J., Matsuoka T., Fujitani Y., Umayahara Y., et al. Beneficial effects of antioxidants in diabetes: possible protection ofpancreatic beta-cells against glucose toxicity. Diabetes 1999, 48:2398-2406.
152. Lee C. Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Clin Chim Acta 2000, 295:141-154.
153. Natella F., Nardini M., Giannetti I., Dattilo C., Scaccini C. Coffee drinking influences plasma anti-oxidant capacity in humans. J Agric Food Chem 2002, 50:6211-6216.
154. Svilaas A., Sakhi A.K., Andersen L.F., Svilaas T., Strom E.C., Jacobs D.R., et al. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 2004, 134:562-567.
155. Hamer M., Chida Y. Intake of fruit, vegetables, and antioxidants and risk of type 2 diabetes: systematic review and meta-analysis. J Hypertens 2007, 25:2361-2369.
156. Natella F., Nardini M., Belelli F., Scaccini C. Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to exvivo oxidation in humans. Am J Clin Nutr 2007, 86:604-609.
157. Somoza V., Lindenmeier M., Wenzel E., Frank O., Erbersdobler H.F., Hofmann T. Activity-guided identification of a chemopreventive compound in coffee beverage using invitro and invivo techniques. J Agric Food Chem 2003, 51:6861-6869.
158. Prasad K., Mantha S.V., Muir A.D., Westcott N.D. Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol Cell Biochem 2000, 206:141-149.
159. Sams D.J., Montague W. The role of adenosine 3':5'-cyclic monophosphate in the regulation of insulin release. Properties of islet-cell adenosine 3':5'-cyclic monophosphate phosphodiesterase. Biochem J 1972, 129:945-952.
160. Lanner J.T., Georgiou D.K., Joshi A.D., Hamilton S.L. Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol 2010, 2:A003996.
161. Bruton J.D., Lemmens R., Shi C.L., Persson-Sjogren S., Westerblad H., Ahmed M., et al. Ryanodine receptors of pancreatic beta-cells mediate a distinct context-dependent signal for insulin secretion. FASEB J 2003, 17:301-303.
162. Shi C.L. Effects of caffeine and acetylcholine on glucose-stimulated insulin release from islet transplants in mice. Cell Transplant 1997, 6:33-37.
163. Choi S.B., Park C.H., Park S. Effect of cola intake on insulin resistance in moderate fat-fed weaning male rats. J Nutr Biochem 2002, 13:727-733.
164. Muroyama K., Murosaki S., Yamamoto Y., Odaka H., Chung H.C., Miyoshi M. Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice. Nutr Sci Vitaminol 2003, 49:56-63.
165. Zheng G., Sayam K., Okubo T., Juneja L.R., Oguni I. Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. InVivo 2004, 18:55-62.
166. Greenberg J.A., Axen K.V., Schnoll R., Boozer C.N. Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes 2005, 29:1121-1129.
167. van Dam R.M., Willett W.C., Manson J.E., Hu F.B. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 2006, 29:398-403.
168. Graham T.E., Sathasivam P., Rowland M., Marko N., Greer F., Battram D. Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test. Can J Physiol Pharmacol 2001, 79:559-565.
169. Bracco D., Ferrarra J.M., Arnaud M.J., Jequier E., Schutz Y. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol 1995, 269:E671-E678.
170. Acheson K.J., Zahorska-Markiewicz B., Anantharaman K., Jequier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr 1980, 33:989-997.
171. Ryu S., Choi S.K., Joung S.S., Suh H., Cha Y.S., Lee S., et al. Caffeine as a lipolytic food component increases endurance performance in rats and athletes. J Nutr Sci Vitaminol 2001, 47:139-146.
172. Greenberg J.A., Boozer C.N., Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr 2006, 84:682-693.
173. Astrup A., Breum L., Toubro S., Hein P., Quaade F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int J Obes Relat Metab Disord 1992, 16:269-277.
174. Jung R.T., Shetty P.S., James W.P.T., Barrand M.A., Callingham B.A. Caffeine: its effects on catecholamines and metabolism in lean and obese subjects. Clin Sci 1981, 60:527-535.
175. Lane J.D., Feinglos M.N., Surwit R.S. Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetes. Diabetes Care 2008, 31:221-222.
176. Debrah K., Sherwin R.S., Murphy J., Kerr D. Effect of caffeine on recognition of and physiological responses to hypoglycaemia in insulin-dependent diabetes. Lancet 1996, 347:19-24.
177. Watson J.M., Jenkins E.J., Hamilton P., Lunt M.J., Kerr D. Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care 2000, 23:455-459.
178. Pimentel G.D., Zemdegs J.C., Theodoro J.A., Mota J.F. Does long-term coffee intake reduce type 2 diabetes mellitus risk?. Diabetol Metab Syndr 2009, 1:6.
179. van Dam R.M. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab 2008, 33:1269-1283.
180. Vaccaro O., Ingrosso D., Rivellese A., Greco G., Riccardi G. Moderate hyperhomocysteinaemia and retinopathy in insulin-dependent diabetes. Lancet 1997, 349:1102-1103.
181. Grubben M.J., Boers G.H., Blom H.J., Broekhuizen R., de Jong R., van Rijt L., et al. Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am J Clin Nutr 2000, 71:480-484.
182. Vaccaro O., Perna A.F., Mancini F.P., Cuomo V., Sacco M., Tufano A., et al. Plasma homocysteine and its determinants in diabetic retinopathy. Diabetes Care 2000, 23:1026-1027.
183. Tavani A., Bertuzzi M., Gallus S., Negri E., La Vecchia C. Diabetes mellitus as a contributor to the risk of acute myocardial infarction. J Clin Epidemiol 2002, 55:1082-1087.
184. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Kokkinos P., Toutouzas P., Stefanadis C. The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study. J Nutr 2003, 133:3228-3232.